1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ono 3307 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ono 3307) | Trials (ono 3307) | Recent Studies (post-2010) (ono 3307) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 12 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aosasa, S; Kinoshita, M; Mochizuki, H; Oda, Y; Ohe, H; Ohkusa, Y; Ono, S; Tamakuma, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ono 3307
| Article | Year |
|---|---|
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
Topics: Aged; Animals; Blood Pressure; Disseminated Intravascular Coagulation; Female; Fibrinolysis; Guanidines; Humans; Male; Middle Aged; Neoplasms; Platelet Activating Factor; Platelet Count; Postoperative Complications; Rabbits; Serine Proteinase Inhibitors; Shock, Septic; Thiazoles; Thiazolidines | 1993 |